View in EDS HTML Full Text PDF Full Text

BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV‐Infected Patients.

Saved in:
Bibliographic Details
Title: BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV‐Infected Patients.
Authors: Pérez-Calvo, Fernando1 (AUTHOR), Jover-Diaz, Francisco1,2 (AUTHOR) fjover@umh.es, Delgado-Sánchez, Elisabet2 (AUTHOR), Peris-García, Jorge1,2 (AUTHOR), Bernabéu-Martínez, María Ángeles3 (AUTHOR), Carradori, Simone (AUTHOR) simone.carradori@unich.it
Source: AIDS Research & Treatment. 12/12/2025, Vol. 2025, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20901240
DOI:10.1155/arat/8818830